PanAgora Asset Management »

Acrivon Therapeutics shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $47k 34k 1.39

More positions owned by PanAgora Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Mastercard Incorporated Cl A (MA)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Philip Morris International (PM)
Wal-Mart Stores (WMT)
Ge Aerospace Com New (GE)

View all positions for PanAgora Asset Management

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Wellington Management Company
Acadian Asset Management
Vanguard Capital Management
Vanguard Group
Renaissance Technologies
Marshall Wace
Acorn Capital Advisors
Two Sigma Investments
Jane Street
Geode Capital Management
BlackRock
GSA Capital Partners
Vanguard Fiduciary Trust

View all funds holding Acrivon Therapeutics